Blood coagulation FV (Factor V) is activated by thrombinmediated excision of the B domain, resulting in a non-covalent heterodimer, FVa (activated FV individually influence FV/FVa by more subtle effects, possibly at the metal ion-dependent subunit interface.
INTRODUCTION
In the presence of Ca 2+ and an aPL (anionic phospholipid)-containing membrane, coagulation FVa [activated FV (Factor V)] accelerates the activation of prothrombin to thrombin by the serine protease FXa (activated Factor X); this represents the critical step of clot generation [1] . Formation of the FVa-FXa-aPL-Ca 2+ complex, termed prothrombinase, is dependent on the activation of FV, which circulates in plasma as a 330 kDa single chain procofactor [2] . FV is structurally and functionally homologous to FVIII (Factor VIII), sharing the domain structure NH 2 -A1-A2-B-A3-C1-C2-COOH [1, 3] . Activation of FV by thrombin or FXa involves removal of the B domain [4] . The resulting FVa is a non-covalent heterodimer composed of a 105 kDa heavy chain (FVaH; domains A1-A2), and a 74/71 kDa light chain (FVaL: domains A3-C1-C2) [5] , held together in the presence of divalent cations [6, 7] . Although the FVaH and FVaL interaction is required for prothrombinase function [6] , little is known about how the divalent cations precisely play their biochemical role.
Bovine FV and FVa have a single high affinity site for Ca 2+ [8] , which must be occupied for FVa subunit association and consequent activity [7] . Ca 2+ does not interact with either FVaH or FVaL alone [9] , suggesting that the Ca 2+ -binding pocket is formed by subunit association. FV also binds with high affinity to one Cu 2+ atom per mole of protein [10] , although an effect of Cu 2+ binding on function has not yet been reported. Based on (1) homology with ceruloplasmin and (2) the crystal structures of an inactivated form of bovine FVa lacking the A2 domain, FVa i [11] , and the human C2 domain [12] , several theoretical models for intact human FVa have been generated [13] [14] [15] [16] . Although these models do not agree on the specific amino acids involved in metal ion binding, there is consensus that an acidic A1 domain loop is involved in Ca 2+ -binding. The loop encompasses Glu 96 , Asp 102 , Glu 108 , Asp 111 and Asp 112 , and is predicted to be located at the A1/A3 domain interface. Most of the structural modelling studies also suggest that the bound Ca 2+ and Cu 2+ are located close to each other. Dissection of human FVa regions by plasmin-mediated fragmentation [17] and studies on mutant FV secreted into culture media [18] from our laboratory provided functional evidence that the amino acids spanning Glu 96 -Asp 111 contribute to the chelatorsensitive heterodimeric subunit complex. In particular, mutation of Asp 111 to Ala appeared to destabilize the association of subunits after single-chain FV was activated to two-chain FVa. Mutation of any combination of amino acids within this region, not just acidic residues, had an inhibitory effect on function [14] . A study by Sorensen et al. [19] later demonstrated that a double mutation in the hypothesized Ca 2+ -binding loop of FV (D111N/D112N) resulted in a rapid loss of activity upon treatment with thrombin. However, the direct involvement of this region with FV-bound metals has not been reported.
To understand the importance of the predicted Ca 2+ -binding loop in FV, we constructed and purified recombinant wild-type FV-810 (wild-type human FV containing part of the B-domain amino acids 710-810, but missing amino acids 811-1491), was cloned into the pMT2 expression vector (pMT2-rFV) [4] and mutants were generated as described in [18] . For each mutant, two complementary oligonucleotides with the desired mutation were amplified using the following primers: 5 -GGTACAGTAAATTA-TCAGCCGGTGCTTCTTACCTTGACCAC-3 (E96A), 5 -AG-GAGCTTCTTACCTTGCCCACACATTCCCTGCG-3 (D102A) and 5 -TCCCTGCGGAGAAGATGGCCGACGCTGTGGCTC-CAG-3 (D111A). Transfection and conditioned media collection were performed as described [4] . Cell cultures were mycoplasmafree. All subsequent steps were carried out at 4
• C. The culture medium was concentrated and loaded onto a SP Sepharose Fast Flow column (Amersham) in 20 mM Mes buffer containing 0.1 M NaCl and 5 mM CaCl 2 , pH 6.0. The column was eluted with a linear NaCl gradient from 0.1 to 0.6 M. Fractions containing FV activity were pooled, centrifuged, loaded onto Q Sepharose Fast Flow (Amersham) in HBS/Ca 2+ (20 mM Hepes buffer containing 0.15 M NaCl and 2 mM CaCl 2 , pH 7.4) and eluted with a linear NaCl gradient from 0.15 to 0.6 M. Fractions containing FV activity were pooled, centrifuged, concentrated and applied to a Superose 6 gel filtration column (Amersham) in HBS/Ca 2+ . Fractions containing FV activity were concentrated and stored at − 80
• C.
Thrombin cleavage of FV-810 and mutants
FV-810 and mutants (200 nM) were incubated with thrombin (0.2 nM) in HBS/Ca 2+ (5 mM) at 22
• C. The digests were stopped at various times by heating at 95
• C for 5 min in denaturing Laemmli sample buffer. Samples were subjected to SDS/PAGE and visualized by Coomassie Blue staining.
Binding of FV-810 and mutants to aPL
Binding curves using SUVs (small unilamellar vesicles) consisting of 25 % phosphatidylserine and 75 % phosphatidylcholine (20 μM) [20] incubated with various concentrations of FV-810 or mutants were obtained by light scattering analysis using a Varian Eclipse fluorescence spectrophotometer [21, 22] . Scattering intensities were measured at 320 nm (excitation and emission) with a band pass of 5 nm at 22
• C. After the manual addition of FV-810 or each mutant, light scattering was followed for 5 min to ensure equilibration. The data were fitted to an equation assuming a single class of sites to derive apparent dissociation constants [K d (app)]. No detectable change in light scattering intensity was observed by SUV in the absence of FV, or by adding FV-810 or mutants without SUV. The changes in light scattering intensity due to dilution by continuous ligand titration were corrected.
FV-810 and mutant prothrombinase activity
To evaluate prothrombinase function, saturating FXa (0.5 nM), SUV (50 μM), prothrombin (1.4 μM) and various concentrations of either FV-810 or mutants in HBS/Ca 2+ with 0.1 % PEG [poly(ethylene glycol)] 8000 were incubated at 22
• C for 5 min. The reaction was terminated with EDTA (15 mM) and thrombin generation was quantified by S2238 (0.2 mM) cleavage using a Spectramax kinetic microplate reader (Molecular Devices) (1-step assay). FV-810 or mutants (100 nM) were also evaluated after pretreatment with thrombin (5 nM) for 5 min, which was sufficient to cleave all of the FV to FVa (2-step assay). Hirudin (0.7 unit/ml) was added at an amount sufficient to inhibit only the thrombin in the pretreatment step. To evaluate prothrombinase function on activated platelets, various concentrations of intact or thrombinpretreated FV-810 or mutants were incubated with excess FXa (0.5 nM), activated platelets (5.4 × 10 4 /30 μl reaction volume) and prothrombin (1.4 μM) and thrombin generation was followed as above. The activated platelets were prepared by incubating fresh platelets (6 × 10 9 /ml) with A23187 (1 μM) for 10 min with gentle agitation. At the concentration of stimulated platelets used, the activity of FV released was minimal and was subtracted from all points.
FV-810 and mutant clotting activity
Various concentrations of FV-810 or mutants (50 μl) in HBS/Ca 2+ were pre-incubated with FV-deficient plasma (50 μl, Biopool) at 37
• C for 1 min in a 1-stage assay. Coagulation was initiated by the addition of Innovin (100 μl, Dade Behring) and the time to clot formation was monitored using an ST4 analyser (Diagnostica Stago). Conversion of FV-810 and mutants to FVa by thrombin was conducted as above in 2-stage assays and evaluated for clotting activity. The clotting times observed were converted into activity units using a human reference plasma standard curve assayed under identical conditions [23] .
FV-810 and mutant subunit dissociation after thrombin cleavage
FVaH dissociation from FVaL bound to SUV was monitored by following a decrease in light scattering as previously reported [24] using a Varian Eclipse fluorimeter. To rapidly convert all of the SUV (20 μM)-bound FV-810 or mutants into FVa, a higher concentration of thrombin was used (100 nM).
Thrombin-cleaved FV-810 and mutant cofactor activity upon chelation
FV-810 or mutants (100 nM) were treated with thrombin (100 nM). Within 1 min, EDTA (5 mM) was added and assayed for clotting activity at various times as above.
Ca

2+ and Cu 2+ bound to FV-810 and mutants
Excess divalent metal ions were removed by extensive dialysis of FV-810 and mutants against HBS-Me (divalent cation-free HBS). HBS-Me was produced by treatment with Chelex-100 resin (Bio-Rad). Samples of FV were then dialysed against HBS-Me with added Ca 2+ (100 nM) and Cu 2+ (100 fM). Prior to analysis, samples were quantified by optical density and diluted 10-fold in 0.1 % metal-free HNO 3. FV-810 and mutants were also pretreated with thrombin in HBS/Ca 2+ before dialysis as above. All samples assayed for Ca 2+ and Cu 2+ were within the linear range of detection by a Varian SpectraAA 300 Zeeman graphite furnace atomic absorption spectrometer. Metal ion standard curves were 
RESULTS
Conversion of FV mutants into FVa by thrombin is normal
SDS/PAGE (Figure 1) showed that FV-810 and mutants were comparably converted within 15 min into FVaH (∼ 105 kDa) and FVaL (∼ 74 kDa) through the anticipated activation intermediate (150 kDa). These data demonstrated that the targeted substitutions did not significantly affect proteolysis of FV-810 by thrombin and established the experimental conditions required for complete proteolysis to FVa. 
Binding of FV mutants to aPL is normal
FV mutant cofactor activity is inhibited
Both prothrombinase chromogenic and clotting assays were performed to evaluate the function of FV-810 and mutants (Figure 3) without (1-stage assay) or with (2-stage assay) thrombin pretreatment. The chromogenic experiments were conducted using either synthetic SUVs ( Figures 3C and 3D 
Subunit stability of FV mutants is differentially altered
When FV-810 and its mutants E96A and D102A were cleaved with thrombin in the presence of metal ions ( Figures 4A, 4C and 4E), no subunit dissociation was detected, which is consistent with the similarity of 1-stage and 2-stage functional assays (Figure 3) . Upon EDTA chelation, FV-810, E96A and D102A subunits dissociated with first-order rates of 0.026 + − 0.0002 min −1 , 0.051 + − 0.0007 min −1 and 0.041 + − 0.0003 min −1 respectively ( Figures 4B, 4D and 4F) . Thus, upon chelation, E96A and D102A had moderately faster FVaH/FVaL dissociation compared with FVa-810. These observations from repeated experiments suggested that Glu 96 and Asp 102 contribute to the metal-dependent subunit interaction of FVa.
In contrast to FV-810, E96A and D102A, the rapid conversion of FV D111A into FVa D111A by thrombin resulted in rapid subunit dissociation (2.1 + − 0.05 min −1 ) even in the presence of metal ions ( Figure 4G ). EDTA chelation did not result in further light scattering changes ( Figure 4H ), indicating that FVa subunits were already completely dissociated. These results clearly demonstrated that the reduction in cofactor activity of D111A is due to spontaneous subunit dissociation.
Chelator-mediated cofactor inhibition precedes subunit dissociation
Having observed that the chelator-mediated FVa subunit dissociation of E96A, D102A and D111A is accelerated, we investigated the rate of cofactor activity loss under identical conditions in parallel. Clotting assays ( Figure 5 ) revealed that FV-810, E96A, D102A and D111A had functional decay rates of 0.9 + − 0.08 min −1 , 1.1 + − 0.07 min −1 , 1.1 + − 0.09 min −1 and 3.1 + − 0.1 min −1 respectively. As expected, the relative cofactor activity of mutants at 0 min compared with FV-810 was inhibited (Figures 3 and 4) . Interestingly, the loss of function for FV-810, E96A and D102A was markedly faster than their corresponding subunit dissociation rates (Figure 4) , suggesting that metal ions may independently affect FVa function and subunit association. D111A clotting activity was negligible within 1 min of EDTA treatment. This observation was anticipated based on the spontaneous subunit dissociation observed by light scattering (Figure 4) . Lee et al. [15] Humanized bovine FVa i [11] and ceruloplasmin A domain homology [38] (1 complicated FVa subunit interaction mechanism by suggesting that correct co-ordination of one metal ion may facilitate that of the other.
DISCUSSION
Ca
2+ -dependent interactions between the subunits of FVa are essential for stability and function [25] , yet little is known about the facilitating amino acids. Five FVa models have been published based on: (i) the crystal structure of ceruloplasmin which shares homology with FVa A-type domains; (ii) the crystal structure of bovine FVa i , which lacks the A2 domain; and (iii) the human recombinant C2 domain crystal structure. Shown in Table 1 [17] and mutated [18, 19] FVa, which demonstrated a role for the Glu 96 -Asp 112 segment in the chelatorsensitive subunit association. This region is represented in most of the models by a Ca 2+ -binding loop and is depicted in Figure 7 (blue peptide backbone) according to the most recent model [15] , which is based on both the humanized bovine FVa i crystal and ceruloplasmin homology. Consistent with a functional role in mediating the FVaH-FVaL interaction, the loop is shown at the A1-A3 interface. Since Ca 2+ and Cu 2+ are proximal to each other in this model, it is plausible that both could affect subunit interactions by influencing Glu 96 -Asp 112 configuration relative to the A3 domain. Compared to other amino acids in the Ca 2+ -binding loop, our preliminary work using recombinant FV secreted into tissue culture medium suggested that single point mutations of Glu 96 , Asp 102 and Asp 111 (Figure 7 ; wireframe) to alanine had the greatest effect on FVa function [18] . To understand further how Ca 2+ and Cu 2+ facilitate FVa activity, we correlated metal ion binding to purified E96A, D102A and D111A with function in the present study. The parental FV-810 produces wild-type FV but has a truncated B domain that does not require proteolytic activation for cofactor function [4] . This unique reagent enabled us to investigate the Ca 2+ dependence of the intra-molecular FVaH-FVaL domain interaction, which is thought to be fully formed prior to excision of the B domain [4] . Figure 8 (A) summarizes our findings. Consistent with Figure 7 , the proposed Ca 2+ -binding loop [11] is shown projecting from the FVaH domain within FV-810, and association with the FVaL domain and Cu 2+ is shown co-ordinating with both the FVaH and FVaL domains. Graphite furnace atomic absorption spectroscopy revealed a stoichiometry of 1:1 FV-810:Ca 2+ , confirming previous literature for the high-affinity binding site [8] . The same molar ratio was derived for Cu 2+ , which was also reported previously [10] .
Of the mutations we studied, altering Asp 111 had the most profound effect on FV/Va function. As predicted by the structural model (Figure 7) , the interaction of D111A with Ca 2+ was severely inhibited, suggesting that Asp 111 provides a pivotal contact with Ca 2+ . This conclusion is supported by most of the FVa models (Table 1 ) and is represented in Figure 8 [27] and that the D111A variant of FV-810 has negligible Ca 2+ -binding, the finding that this 60 %-active mutant retained significant cofactor function was unexpected. These results suggest that in addition to masking FV cofactor activity [4] , the B domain facilitates a functional configuration between the FVaH and FVaL domains even in the absence of proper metal ion co-ordination ( Figure 8B ). After this stabilizing effect of the B domain is excised from D111A, the importance of metals is highlighted by complete inhibition and rapid dissociation of the non-covalent subunits.
To evaluate the multi-functional role of the Ca 2+ -binding loop implied by our earlier preliminary studies [18] , we investigated the effect of mutating Glu 96 and Asp 102 to alanine on FV/FVa function. Unlike D111A, the stoichiometry for Ca 2+ and Cu 2+ bound to E96A or D102A was shown here to be identical to FV-810. E96A and D102A nevertheless had reduced cofactor activity. The structural model ( Figure 7) indicates that both or either could contribute directly to inter-subunit contact. Although the interaction of FVaH and FVaL derived from thrombin-cleaved E96A and D102A was stable in the presence of metal ions, mutation moderately enhanced chelator-mediated dissociation. The close proximity of Glu 96 and Asp 102 to the probable Ca 2+ -binding site may thus confer a subtle effect on metal ion coordination that enhances the susceptibility to chelation and subunit dissociation due to EDTA.
For human FVIII, Cu 2+ enhances the affinity between subunits [28] . Ca 2+ binds to a region in FVIII nearly identical to the Ca 2+ -binding loop of FV [29, 30] and results in conformational changes that probably participate in subunit association and in the formation of active cofactor. Roles for Cu 2+ have not been reported for human FVa subunit association and function. For bovine FVa, Ca 2+ alone appears to facilitate reassociation of isolated subunits, giving rise to full function [7] . In our studies, it was not possible to completely remove Cu 2+ bound to FV-810 by extensive dialysis against a chelating resin (results not shown). Therefore, the involvement of Cu 2+ in FVaH-FVaL association and function of human FVa cannot be excluded at this time and may be especially difficult to assess if indeed there is metal ion interdependent binding in FVa as hypothesized here.
The chelator-induced subunit dissociation rate measured quantitatively for FVa-810 in the current work (t 1 2 ≈ 35 min) was c The Authors Journal compilation c 2009 Biochemical Society comparable with that previously reported for human FVa [18] . Interestingly, this was approx. 10-fold slower than the rate of activity loss we measured, which is similar to several previously published observations using analogous methods in solution [6, 8, 31] . Although these reports differ from results acquired using a unique solid-phase activity assay [17] , the preponderance of evidence in the literature, combined with the results presented in this study, suggest that FVa cofactor function is lost due to chelation prior to subunit dissociation ( Figure 8A) . A similar mechanism was proposed for FVIII by Fay and co-workers, who observed formation of inactive heterodimer in the absence of metal ions [28] . Only in the presence of both Ca 2+ and Cu 2+ did these authors observe a high FVIII-specific activity. Further experimentation is required to confirm that metal ion binding to FVa may not only contribute to subunit association but also to distinctly induce a functional conformation. Although extremely rare, X-linked FVIII deficiency is approximately two orders of magnitude more prevalent than the homozygous deficiency of FV. A relatively large number of mutations associated with FVIII deficiency have consequently been identified and have enabled correlations between individual amino acids and function [17] . Patients carrying substitutions in the probable Ca 2+ -binding loop in FV have not been reported. However, homologous mutations have been identified in FVIII, which result in haemophilia A [32] [33] [34] [35] . In the present study, coagulation assays revealed nearly 100 % inhibition after cleavage of D111A by thrombin, in contrast with only a partial loss of activity without thrombin pretreatment. To our knowledge, this 1-stage/2-stage assay discrepancy has not been reported clinically for FV but has been shown in naturally occurring haemophilia A mutations [36, 37] . This raises the possibility that FV mutation resulting in impaired metal binding or subunit interface contact may be a previously overlooked basis of pathology.
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